PHARMA

Quarterly rpt on consolidated results for the financial period ended 30 Sep 2019

PHARMANIAGA BERHAD

Financial Year End 31 Dec 2019
Quarter 3 Qtr
Quarterly report for the financial period ended 30 Sep 2019
The figures have not been audited

Attachments

Pharma Q3 2019.pdf
280.3 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2019

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Sep 2019
30 Sep 2018
30 Sep 2019
30 Sep 2018
$$'000
$$'000
$$'000
$$'000
1 Revenue
716,849
587,660
2,104,847
1,788,312
2 Profit/(loss) before tax
3,885
17,603
46,609
58,280
3 Profit/(loss) for the period
376
15,305
29,286
38,660
4 Profit/(loss) attributable to ordinary equity holders of the parent
481
15,051
29,379
38,031
5 Basic earnings/(loss) per share (Subunit)
0.18
5.79
11.26
14.63
6 Proposed/Declared dividend per share (Subunit)
0.00
5.00
8.50
14.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
1.9800
1.9600

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 20 Nov 2019
Category Financial Results
Reference Number FRA-11112019-00002